| Views | |
|---|---|
| Development of a transcutaneous form of desloratadine | 116 |
| March 2026 | April 2026 | May 2026 | June 2026 | July 2026 | August 2026 | September 2026 | |
|---|---|---|---|---|---|---|---|
| Development of a transcutaneous form of desloratadine | 4 | 3 | 5 | 7 | 8 | 19 | 4 |
| Views | |
|---|---|
| Ageev_Development_24.pdf | 72 |
| Views | |
|---|---|
| United States | 39 |
| Canada | 8 |
| China | 5 |
| Germany | 4 |
| EU | 3 |
| United Kingdom | 3 |
| India | 3 |
| Russia | 2 |
| Australia | 1 |
| Brazil | 1 |
| Views | |
|---|---|
| Houston | 13 |
| Mountain View | 9 |
| Ottawa | 8 |
| Dearborn | 4 |
| San Francisco | 4 |
| Beijing | 3 |
| Mumbai | 3 |
| Sacramento | 3 |
| Darmstadt | 2 |
| Palo Alto | 2 |